Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COMPARISON OF SWITCHING PRASUGREL OR TICAGRELOR IN ELDERLY PATIENTS WITH CORONARY ARTERY DISEASE ON CLOPIDOGREL THERAPY WITH HIGH PLATELET REACTIVITY: A RANDOMIZED PHARMACODYNAMIC STUDY EFECTOS DEL CAMBIO A PRASUGREL O TICAGRELOR EN PACIENTES ANCIANOS CON ENFERMEDAD CORONARIA EN TRATAMIENTO CRONICO CON CLOPIDOGREL Y ELEVADA REACTIVIDAD PLAQUETARIA: ESTUDIO FARMACODINAMICO ALEATORIZADO

Trial Profile

COMPARISON OF SWITCHING PRASUGREL OR TICAGRELOR IN ELDERLY PATIENTS WITH CORONARY ARTERY DISEASE ON CLOPIDOGREL THERAPY WITH HIGH PLATELET REACTIVITY: A RANDOMIZED PHARMACODYNAMIC STUDY EFECTOS DEL CAMBIO A PRASUGREL O TICAGRELOR EN PACIENTES ANCIANOS CON ENFERMEDAD CORONARIA EN TRATAMIENTO CRONICO CON CLOPIDOGREL Y ELEVADA REACTIVIDAD PLAQUETARIA: ESTUDIO FARMACODINAMICO ALEATORIZADO

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms ESTUDIO PRATICEL; PRATICEL STUDY

Most Recent Events

  • 04 Nov 2016 Status changed from recruiting to discontinued.
  • 30 Jun 2014 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top